US Broker Ratings

Baxter International Inc. (BAX) Stock Analysis: Exploring a 23.56% Potential Upside Amid Healthcare Industry Dynamics

Investors seeking opportunities in the healthcare sector might find Baxter International Inc. (BAX) an intriguing candidate, especially given its potential upside of 23.56% based on current..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Growth in the Medical Devices Sector with a 10% Upside Potential

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has long been a stalwart in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a Tight Range with a 0.97% Potential Upside

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare plans sector, is currently drawing the attention of investors navigating a volatile market landscape. With..

Quest Diagnostics (DGX) Stock Analysis: Insights into a 9.41% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, specifically within the Diagnostics & Research industry, offers intriguing prospects for individual investors. With..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 43% Potential Upside for Investors

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector specializing in diagnostics and research, offers an intriguing investment narrative with its impressive market..

UnitedHealth Group (UNH) Stock Analysis: A Compelling 28.52% Potential Upside in Healthcare

UnitedHealth Group Incorporated (UNH), a titan in the healthcare sector, commands attention with its substantial market cap of $256.05 billion. This industry leader, based in Eden..

Agilent Technologies, Inc. (A) Stock Analysis: A 46% Potential Upside Fuels Investor Optimism

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, specifically in diagnostics and research, is drawing significant attention from investors due to its..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 16.64% Potential Upside

Investors with an eye on the healthcare sector should take note of Labcorp Holdings Inc. (NYSE: LH), a key player in the Diagnostics & Research industry...

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Potential 27.91% Upside Amidst Robust Revenue Growth

Mettler-Toledo International, Inc. (NYSE: MTD) has long been a notable player in the diagnostics and research sector, providing precision instruments and services across the globe. Headquartered..

Regeneron Pharmaceuticals (REGN) Investor Outlook: Potential 17% Upside Amid Robust Pipeline

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has long been a stalwart in the biotechnology sector, and recent financial data suggests that it continues to hold significant promise..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a Healthy Growth Path with a $119 Billion Market Cap

HCA Healthcare, Inc. (NYSE: HCA), a stalwart in the medical care facilities industry, continues to capture the attention of investors with its robust market presence and..

Merck & Company, Inc. (MRK) Stock Analysis: A Healthcare Powerhouse with 10.52% Upside Potential

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to be a focal point for investors seeking robust growth and steady income...

Pfizer, Inc. (PFE) Stock Analysis: Dividend Yield Shines Amidst Mixed Valuation Signals

Pfizer, Inc. (NYSE: PFE) remains a significant player within the healthcare sector, specifically in the drug manufacturing industry. With a market capitalization of $151.14 billion, Pfizer’s..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 51% Potential Upside in Healthcare Software

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software for the life sciences industry, is garnering significant attention from investors. With a current market capitalization..

Alnylam Pharmaceuticals (ALNY): Investor Outlook Highlights 45.82% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering force in the biotechnology sector, offers a compelling case for investors with its innovative approach to drug development using..

Becton, Dickinson and Company (BDX) Stock Analysis: Unlocking 23.72% Potential Upside with Strong Healthcare Innovations

Becton, Dickinson and Company (NYSE: BDX), a cornerstone in the medical instruments and supplies industry, continues to command attention from investors with its robust market presence..

McKesson Corporation (MCK) Stock Analysis: Navigating Growth and Opportunity with a 5.78% Potential Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a pivotal player in the medical distribution industry. With a market capitalization of $116.13..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unraveling a 30.74% Potential Upside in the Healthcare Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of..

The Cigna Group (CI) Stock Analysis: Unpacking a 26.80% Potential Upside for Investors

As the healthcare sector continues to evolve, The Cigna Group (CI) stands out as a formidable player within the healthcare plans industry. With a market capitalization..

Sanofi (SNY) Stock Analysis: A 32% Upside Potential with a Strong Dividend Yield

Sanofi (NASDAQ: SNY), a heavyweight in the healthcare sector, presents itself as a compelling opportunity for investors seeking both stability and growth potential. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds